Product catalog
Products are shown once even when a blend contains several tracked components. Each card distinguishes flat all-dose pricing, dose-dependent pricing, and starting-price-only offers so a low entry price is not mistaken for a high-dose price. Dose and strength details are provider-stated catalog information, not dosing advice.
A current product surface and active public access path establish that the product is listed.
Current price verified · checked Aug 18, 2026
A current product surface and active public access path establish that the product is listed.
Provider price discrepancy: current provider pages list $97.00 and $175.00 per month. We display the higher $175.00 amount and exclude it from lowest-price rankings.
| Dose or option | Supply | Current price | Source |
|---|---|---|---|
| Generic GLP-1 current-page conflict | Weekly compounded GLP-1 injection in which the clinician selects semaglutide or tirzepatide as alternatives, not a blend; direct offer states four doses/month. | $175.00 per month (higher provider price shown; provider also lists $97.00) | Price source |
| Compounded semaglutide component-specific observation | Weekly compounded GLP-1 injection in which the clinician selects semaglutide or tirzepatide as alternatives, not a blend; direct offer states four doses/month. | Price not publicly listed | Price source |
| Compounded tirzepatide component-specific observation | Weekly compounded GLP-1 injection in which the clinician selects semaglutide or tirzepatide as alternatives, not a blend; direct offer states four doses/month. | Price not publicly listed | Price source |
| One-month experiment plan | Weekly compounded GLP-1 injection in which the clinician selects semaglutide or tirzepatide as alternatives, not a blend; direct offer states four doses/month. | Price not publicly listed | Price source |
| Three-month experiment plan | Weekly compounded GLP-1 injection in which the clinician selects semaglutide or tirzepatide as alternatives, not a blend; direct offer states four doses/month. | Price not publicly listed | Price source |
| Six-month experiment plan | Weekly compounded GLP-1 injection in which the clinician selects semaglutide or tirzepatide as alternatives, not a blend; direct offer states four doses/month. | Price not publicly listed | Price source |
| Twelve-month experiment plan conflict | Weekly compounded GLP-1 injection in which the clinician selects semaglutide or tirzepatide as alternatives, not a blend; direct offer states four doses/month. | $1,980.00 per program package (higher provider price shown; provider also lists $165.00 or $199.00) | Price source |
Provider price discrepancy; higher current price shown · checked Aug 18, 2026
A current product surface and active public access path establish that the product is listed.
Current price verified · checked Aug 18, 2026
A current product surface and active public access path establish that the product is listed.
Provider price discrepancy: current provider pages list $69.00 and $89.00 per program package. We display the higher $89.00 amount and exclude it from lowest-price rankings.
| Dose or option | Supply | Current price | Source |
|---|---|---|---|
| Current 30-capsule price conflict | Consumer oral complex containing KPV, BPC-157, GHK-Cu and Larazotide plus nonqualifying supporting ingredients; 30 capsules, one capsule/day per FAQ, with component amounts not public. | $89.00 per program package (higher provider price shown; provider also lists $69.00) | Price source |
Provider price discrepancy; higher current price shown · checked Aug 18, 2026
A current product surface and active public access path establish that the product is listed.
Provider price discrepancy: current provider pages list $77.00 and $117.00 and $155.00 per month. We display the higher $155.00 amount and exclude it from lowest-price rankings.
| Dose or option | Supply | Current price | Source |
|---|---|---|---|
| Current four-dose monthly price conflict | Weekly compounded microdose GLP-1 injection in which semaglutide or tirzepatide are alternatives, not a blend; four doses/month. | $155.00 per month (higher provider price shown; provider also lists $77.00 or $117.00) | Price source |
Provider price discrepancy; higher current price shown · checked Aug 18, 2026
A current product surface and active public access path establish that the product is listed.
Current price verified · checked Aug 18, 2026
A current product surface and active public access path establish that the product is listed.
Provider price discrepancy: current provider pages list $179.00 and $199.00 per documented billing option. We display the higher $199.00 amount and exclude it from lowest-price rankings.
| Dose or option | Supply | Current price | Source |
|---|---|---|---|
| Current NAD+ injection price conflict | NAD+ injection; support copy conflicts between 100 mg/vial in 5 mL and a 5 mL vial at 200 mg/mL, so no total strength is normalized. | $199.00 per documented billing option (higher provider price shown; provider also lists $179.00) | Price source |
Provider price discrepancy; higher current price shown · checked Aug 18, 2026
A current product surface and active public access path establish that the product is listed.
Current price verified · checked Aug 18, 2026
A current product surface and active public access path establish that the product is listed.
Current price verified · checked Aug 18, 2026
A current product surface and active public access path establish that the product is listed.
Provider price discrepancy: current provider pages list $175.00 and $179.00 and $225.00 per documented billing option. We display the higher $225.00 amount and exclude it from lowest-price rankings.
| Dose or option | Supply | Current price | Source |
|---|---|---|---|
| One-month plan — upfront total | Sermorelin injection at support-stated 3 mg/mL; vial volume is not public. Exact term plans include medication if prescribed, provider review, injection supplies, support and shipping. | $225.00 per program package | Price source |
| Three-month plan — upfront total | Sermorelin injection at support-stated 3 mg/mL; vial volume is not public. Exact term plans include medication if prescribed, provider review, injection supplies, support and shipping. | $585.00 per program package | Price source |
| Three-month plan — provider displays $195/month | Sermorelin injection at support-stated 3 mg/mL; vial volume is not public. Exact term plans include medication if prescribed, provider review, injection supplies, support and shipping. | $195.00 per month | Price source |
| Six-month plan — upfront total | Sermorelin injection at support-stated 3 mg/mL; vial volume is not public. Exact term plans include medication if prescribed, provider review, injection supplies, support and shipping. | $1,050.00 per program package | Price source |
| Six-month plan — provider displays $175/month | Sermorelin injection at support-stated 3 mg/mL; vial volume is not public. Exact term plans include medication if prescribed, provider review, injection supplies, support and shipping. | $175.00 per month | Price source |
| Unallocated current headline conflict | Sermorelin injection at support-stated 3 mg/mL; vial volume is not public. Exact term plans include medication if prescribed, provider review, injection supplies, support and shipping. | $225.00 per documented billing option (higher provider price shown; provider also lists $175.00 or $179.00) | Price source |
Provider price discrepancy; higher current price shown · checked Aug 18, 2026
Prices and strength options are provider-stated snapshots and can change by formulation, state, eligibility, commitment, shipping, and subscription.
Help expand the directory
Email us at contact@PeptideProviderHub.com or visit the contact page for the information to include.